Characterization of novel HIV fusion-inhibitory lipopeptides with the M-T hook structure
Microbes and Infection · 2024-11 · 26 (8) · 105366
DOI: 10.1016/j.micinf.2024.105366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbes and Infection, 2024-11. Verfasst von Xiuzhu Geng und 4 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medi…. Hauptthemen laut MEDLINE: Lipopeptides, Macaca mulatta, HIV-1, HIV Fusion Inhibitors. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: CAMS Innovation Fund for Medical Sciences, Chinese Academy of Meteorological Sciences, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
Combination antiretroviral therapy (cART) has significantly improved the survival of HIV-infected individuals, but long-term treatment can cause side-effects and drug resistance; thus, the development of new antivirals is of importance. We previously identified an M-T hook structure and accordingly designed short-peptide fusion inhibitor 2P23, which mainly targets the gp41 pocket site and displays potent, broad-spectrum anti-HIV activity. In this study, we continuingly characterized the amino acid sequences of peptide and lipopeptide-based inhibitors containing the M-T hook residues. Among a group of lipopeptides, stearic acid (C18)-modified LP-25 and LP-29 exhibited greatly improved inhibitions against divergent HIV-1 subtypes and drug-resistant mutants. LP-25 and LP-29 were evaluated in rhesus macaques, and the ex vivo inhibition data demonstrated their potent, long-lasting in vivo anti-HIV activity, with LP-25 much better than LP-29. Both the lipopeptides displayed high α-helicity, thermostability and binding ability to a target-mimic peptide, and they were metabolically stable when treated with high temperature, proteolytic enzymes, human or monkey sera and human liver microsomes. Therefore, our studies have provided critical information for understanding the structure-activity relationship of HIV fusion inhibitors with the M-T hook structure and offered novel candidates for drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China; Center for AIDS Research, Chinese…
Förderung
- CAMS Innovation Fund for Medical Sciences
- Chinese Academy of Meteorological Sciences
- Natural Science Foundation of Beijing Municipality
- National Natural Science Foundation of China
Zitieren
APA
Geng, X., Ding, X., Zhu, Y., Chong, H., & He, Y. (2024). Characterization of novel HIV fusion-inhibitory lipopeptides with the M-T hook structure. Microbes and Infection, 26(8), 105366. https://doi.org/10.1016/j.micinf.2024.105366
Vancouver
Geng X, Ding X, Zhu Y, Chong H, He Y. Characterization of novel HIV fusion-inhibitory lipopeptides with the M-T hook structure. Microbes and Infection. 2024;26(8):105366. doi:10.1016/j.micinf.2024.105366
BibTeX
@article{Geng2024,
author = {Geng, Xiuzhu and Ding, Xiaohui and Zhu, Yuanmei and Chong, Huihui and He, Yuxian},
title = {Characterization of novel HIV fusion-inhibitory lipopeptides with the M-T hook structure},
journal = {Microbes and Infection},
year = {2024},
volume = {26},
number = {8},
pages = {105366},
doi = {10.1016/j.micinf.2024.105366}
}
EUVIMED